Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06953180 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 11, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv3
  2. Site contact updatedv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Asfendiyarov Kazakh National Medical University
3 trials monitored
See all monitored trials
Heart Disease
8,786 trials monitored
See 412 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
and 2 more diseases
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.
Trial Details
NCT Number NCT06953180
Lead Sponsor Asfendiyarov Kazakh National Medical University
Conditions
(from sponsor)		 Cardiovascular Diseases (CVD), Type 2 Diabetes, Chronic Respiratory Diseases, Obesity (Disorder), Chronic Kidney Diseases
Related terms Cardiovascular Diseases, Diabetes Mellitus, Type 2, Obesity, Renal Insufficiency, Chronic
Enrollment 6,720 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov